No: And Anyway, The HGP Isn't `Big Science'

Molecular biology is sophisticated conceptually, but the routine tasks are repetitive, manual labor. The human genome project is developing many automated techniques for molecular biology, including those for mapping and sequencing. In addition, thanks to the project, critical new computation-al tools for biology are being invented and the most sophisticated approaches in mo- dern computer science are being applied to biology. The technology imperatives of the HGP require interdisciplinary eff

Written byLeroy Hood
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The technology imperatives of the HGP require interdisciplinary efforts, bringing together the techniques of chemistry, computer science, engineering, applied math, physics, and biology. The complex problems of modern biology demand these interdisciplinary collaborations, and the HGP has been catalytic in this regard. Moreover, the HGP is training a new type of interdisciplinary biologist who understands technology as well as biology. I believe these multidisciplinary biologists will be among the scientific leaders of the 21st century.

America currently is the world leader in biotechnology. This leadership is being threatened by the Japanese. The HGP, through both its technology and the creation of a powerful biological infrastructure, will help ensure this world leadership in the future. In this regard, let me make two points. First, biotechnology offers an opportunity to redress America's failure in industrial competitiveness and the negative trade balance. Let me give you an example: In 1981, a small venture ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies